Re: Vitamin D: Health panacea or false prophet?

Nutrition

Volumn 29, Issue 5, 2013, Pages 809-810

  Grant, William B ^a   Holick, Michael F ^b  

^a Sunlight   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; APOLIPOPROTEIN E4; CALCITRIOL; CATHELICIDIN; COD LIVER OIL; VITAMIN D RECEPTOR;

AGING; ALTITUDE; AUTOIMMUNE DISEASE; B LYMPHOCYTE ACTIVATION; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; HUMAN; IMMUNOMODULATION; INFECTION RISK; INFLUENZA A; INNATE IMMUNITY; LETTER; LIFE EXPECTANCY; MORTALITY; PRIORITY JOURNAL; PROPHYLAXIS; RISK REDUCTION; SURVIVAL RATE; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS; ULTRAVIOLET B RADIATION; VITAMIN D DEFICIENCY;

ANIMALS; FEMALE; HUMANS; MALE; PREGNANCY; VITAMIN D;

EID: 84876339542     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2013.01.008     Document Type: Letter

References (15)

1. Glade M.J. Vitamin D: Health panacea or false prophet?. Nutrition 2013, 29:37-41.
2. Grant W.B. Ecological studies of the UVB-vitamin D-cancer hypothesis; review. Anticancer Res 2012, 32:223-236.
3. Grant W.B., Peiris A.N. Differences in vitamin D status may account for unexplained disparities in cancer survival rates between African and White Americans. Dermatoendocrinol 2012, 4:85-94.
4. Grant W.B. Role of solar UV irradiance and smoking in cancer as inferred from cancer incidence rates by occupation in Nordic countries. Dermatoendocrinol 2012, 4:203-211.
5. Hill A.B. The environment and disease: Association or causation?. Proc R Soc Med 1965, 58:295-300.
6. Grant W.B. How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer? An examination using Hill's criteria for causality. Dermatoendocrinol 2009, 1:17-24.
7. Mohr S.B., Gorham E.D., Alcaraz J.E., Kane C.I., Macera C.A., Parsons J.E., et al. Does the evidence for an inverse relationship between serum vitamin D status and breast cancer risk satisfy the Hill criteria?. Dermatoendocrin 2012, 4:152-157.
8. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
9. Urashima M., Segawa T., Okazaki M., Kurihara M., Wada Y., Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 2010, 91:1255-1260.
10. Jablonski N.G., Chaplin G. Colloquium paper: human skin pigmentation as an adaptation to UV radiation. Proc Natl Acad Sci U S A 2010, 107(suppl 2):8962-8968.
11. Kulminski A.M., Culminskaya I., Ukraintseva S.V., Arbeev K.G., Arbeeva L., Wu D., et al. Trade-off in the effects of the apolipoprotein E polymorphism on the ages at onset of CVD and cancer influences human lifespan. Aging Cell 2011, 10:533-541.
12. Huebbe P., Nebel A., Siegert S., Moehring J., Boesch-Saadatmandi C., Most E., et al. APOE ε4 is associated with higher vitamin D levels in targeted replacement mice and humans. FASEB J 2011, 25:3262-3270.
13. Wang L., Song Y., Manson J.E., Pilz S., März W., Michaëlsson K., et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: A meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 2012, 5:819-829.
14. Afzal S., Bojesen S.E., Nordestgaard B.G. Low 25-hydroxyvitamin D and risk of type 2 diabetes: A prospective cohort study and meta-analysis. Clin 2013, 59:381-391.
15. Grant W.B. An estimate of the global reduction in mortality rates through doubling vitamin D levels. Eur J Clin Nutr 2011, 65:1016-1026.